Press "Enter" to skip to content

New patent for Teva Branded drug PROAIR DIGIHALER

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Branded drug PROAIR DIGIHALER

Annual Drug Patent Expirations for PROAIR+DIGIHALER
Annual Drug Patent Expirations for PROAIR+DIGIHALER

Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting this drug.

Drug patent litigation for PROAIR DIGIHALER.

This drug has two hundred and ninety-nine patent family members in thirty-one countries.

The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. Two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Teva Branded drug PROAIR DIGIHALER
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions